Campbell & CO Investment Adviser LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1353570 BALTIMORE, MD

Position in VRTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,491,693

-$1,977,529 QoQ

Shares Held

5,580

-43.4% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $45,287,811 across 43 Biotechnology names. VRTX ranks #5 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	9,034	$6,597,078
2	KRYS	Krystal Biotech, Inc.	17,795	$4,596,804
3	CRNX	Crinetics Pharmaceuticals, Inc.	83,617	$3,036,969
4	RVMD	Revolution Medicines, Inc.	29,130	$2,832,892
5	VRTX	Vertex Pharmaceuticals Inc / Ma This page	5,580	$2,491,693
6	TECH	BIO-TECHNE Corp	41,339	$2,160,376
7	RPRX	Royalty Pharma plc	31,202	$1,496,759
8	PRTA	Prothena Corp Public Ltd Co	142,587	$1,385,945

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,491,693	5,580	-43.4%	Shares	Sole	2026-05-15
2025-12-31	$4,469,222	9,858	+387.3%	Shares	Sole	2026-02-12
2025-09-30	$792,287	2,023	+66.5%	Shares	Sole	2025-10-28
2024-09-30	$565,072	1,215	-19.2%	Shares	Sole	2024-11-12
2024-06-30	$704,486	1,503	+51.2%	Shares	Sole	2024-08-13
2024-03-31	$415,501	994	-81.6%	Shares	Sole	2024-05-10
2023-12-31	$2,192,323	5,388	+146.9%	Shares	Sole	2024-02-13
2023-09-30	$758,768	2,182	+53.9%	Shares	Sole	2023-11-08
2023-06-30	$499,008	1,418	+15.2%	Shares	Sole	2023-08-11
2023-03-31	$387,851	1,231	-69.7%	Shares	Sole	2023-05-11
2022-12-31	$1,172,446	4,060	+113.7%	Shares	Sole	2023-02-14
2021-09-30	$344,641	1,900	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.